India Exchange Filings

Shukra Medtech Q2 FY27 Earnings Summary

Shukra Pharmaceuticals Ltd reports Q2 FY27 revenue of ₹44.20 crore and net profit of ₹16.01 crore

  • Revenue rose 652% YoY; net profit increased 573% YoY.
  • EBITDA was ₹22.01 crore, at a 49.8% margin, versus negative EBITDA in Q2 FY26.
  • Profit before tax was ₹21.13 crore, compared with ₹0.20 crore a year earlier.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.